University of Cambridge seeks a motivated PhD student to investigate malignant cell-intrinsic and -extrinsic resistance mechanisms to KRAS inhibitors in PDAC. The project combines organoid models, mouse transplantations, single-cell RNA sequencing and spatial profiling to define genetic heterogeneity effects on therapy response.
The candidate will work in a collaborative lab with a strong emphasis on experimental and computational approaches, contributing to publication-quality studies and
#J-18808-Ljbffr
PhD: Unmasking KRAS Resistance in Pancreatic Cancer in Cambridge employer: University of Cambridge
The University of Cambridge offers a dynamic and collaborative work environment, particularly within the Department of Oncology, where you will play a pivotal role in advancing cancer research. With a strong emphasis on employee growth, you will have access to professional development opportunities and the chance to work alongside leading experts in the field. The university's commitment to innovation and excellence ensures that your contributions will have a meaningful impact on clinical care and research outcomes.
